Yuta Maruki | Medicine and Health Sciences | Innovative Research Award

Published on by Research Scientist

Innovative Research Award

Yuta Maruki — National Cancer Center Hospital, Tokyo, Japan

Yuta Maruki
Affiliation National Cancer Center Hospital
Country Japan
Scopus ID 57204573534
Documents 67
Citations 452
h-index 11
Subject Area Medicine and Health Sciences
Event International Research Scientist Awards
ORCID 0000-0002-5045-8082

Yuta Maruki is a physician and clinical researcher at the National Cancer Center Hospital in Tokyo, Japan, whose documented work focuses on hepatobiliary and pancreatic oncology. His research and publications encompass biliary tract cancer, molecular oncology, endoscopic treatment, genomic profiling, procedural sedation, and clinically oriented cancer research. [1]

Abstract

Yuta Maruki is a physician and clinical researcher at the National Cancer Center Hospital in Tokyo, Japan, working in hepatobiliary and pancreatic oncology. His published research addresses biliary tract cancer, FGFR2 rearrangements, endoscopic management, pancreatic cancer genomic profiling, sedation during therapeutic endoscopy, and treatment strategies for hepatocellular carcinoma. His publication record includes prospective observational research, technical endoscopy studies, clinical investigations, and contemporary molecular oncology work. These areas connect translational cancer biology with practical diagnostic and therapeutic care, providing a documented scholarly profile relevant to an Innovative Research Award consideration within medicine and health sciences through multidisciplinary research and care delivery.

Keywords

Biliary tract cancer, cholangiocarcinoma, FGFR2 rearrangements, molecular oncology, genomic profiling, pancreatic cancer, endoscopic ultrasound, biliary drainage, malignant biliary strictures, propofol sedation, therapeutic endoscopy, hepatocellular carcinoma, pharmacological downstaging, precision oncology, biomarker analysis, clinical trials, translational cancer research, and hepatobiliary oncology. molecular diagnostics and precision therapeutic approaches

Introduction

Yuta Maruki’s research profile is situated within hepatobiliary and pancreatic oncology, where molecular characterization and interventional endoscopy intersect with clinical decision making. His studies examine relevant questions involving biliary tract malignancies, pancreatic cancer, and therapeutic procedures. The work reflects collaboration across oncology, pathology, genomics, gastroenterology, and clinical research in Japan. [2]

Research Profile

Yuta Maruki is identified by the National Cancer Center Hospital as an attending physician specializing in hepatobiliary and pancreatic disease, with involvement in clinical trials and research. His institutional profile also describes gastrointestinal endoscopic practice, including gastroscopy and endoscopic retrograde cholangiopancreatography. His documented publications span molecular oncology and therapeutic endoscopy. [2]

Research Contributions

Yuta Maruki’s publications address connected research themes. The PRELUDE study investigated FGFR2 rearrangements in advanced or recurrent biliary tract carcinoma, while later work examined molecular features of cholangiocarcinoma and treatment. Other studies address endoscopic drainage, genomic tissue acquisition, propofol sedation, and pharmacological downstaging, illustrating a broad research portfolio in oncology. [3]

Publications

Yuta Maruki has published on FGFR2 rearrangements in biliary tract carcinoma, endoscopic drainage of malignant biliary strictures, propofol sedation during biliary and pancreatic procedures, genomic profiling of unresectable pancreatic cancer, and pharmacological downstaging in hepatocellular carcinoma. Recent work also includes molecular classification and treatment experience involving FGFR-directed therapy in cholangiocarcinoma. [3] [4]

Research Impact

Yuta Maruki’s research impact can be described through the relevance and continuity of his publication themes than through unsupported claims. His studies contribute evidence concerning molecular testing, endoscopic techniques, genomic profiling, procedural safety, and treatment selection. Citation metrics supplied for this profile indicate 452 citations and an h-index of 11. [3]

Award Suitability

Yuta Maruki’s documented research record provides evidence-based areas for consideration in an Innovative Research Award context, including translational oncology, molecular characterization of biliary cancers, therapeutic endoscopy, and clinically oriented cancer research. His publications demonstrate sustained engagement with multidisciplinary questions connecting laboratory-informed biomarkers, diagnostic procedures, treatment strategies, and patient-focused clinical practice. [4]

Conclusion

Yuta Maruki’s profile combines specialist clinical practice with research in hepatobiliary and pancreatic oncology. His publications address molecular alterations, cancer diagnostics, endoscopic interventions, procedural safety, and therapeutic strategies. The available institutional and publication records provide a factual basis for describing his research trajectory and relevance to medicine and health sciences. [2]

References

  1. National Cancer Center Hospital. Yuta Maruki — Department of Hepatobiliary and Pancreatic Oncology.
    https://phase1-oncol.ncc.go.jp/en/members/yuta-maruki/
  2. Maruki, Y., Morizane, C., Arai, Y., et al. (2021). Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study). Journal of Gastroenterology.
    https://doi.org/10.1007/s00535-020-01735-2
  3. Maruki, Y., Hijioka, S., Yagi, S., et al. (2025). Sedative effects of propofol and risk factors for excessive sedation in the endoscopic treatment of biliary and pancreatic diseases. DEN Open, 5(1), e417.
    https://doi.org/10.1002/deo2.417
  4. Maruki, Y., Yatabe, Y., Mizoguchi, C., et al. (2026). FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study. Hepatology Research.
    https://doi.org/10.1111/hepr.70031
  5. Maruki, Y., Morizane, C., et al. (2025). First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms26125586

Payam Younesi Baneh | Medicine and Health Sciences | Editorial Board Member

Published on by Research Scientist

Mr. Payam Younesi Baneh | Medicine and Health Sciences | Editorial Board Member

Dental Intern | Kurdistan University of Medical Sciences | Iran

Mr. Payam Younesi Baneh is an emerging researcher at the Kurdistan University of Medical Sciences, Sanandaj, Iran, specializing in environmental health sciences with a particular focus on groundwater quality, heavy metal contamination, and public health risk assessment. His research contributions reflect a strong commitment to addressing critical environmental challenges that directly impact community health and sustainable development within rural and underserved regions.He has authored scholarly work indexed in Scopus, including his notable open-access article Assessment of heavy metal contamination in groundwater of rural areas of Kurdistan Province Iran: A comprehensive study published in Heliyon . This study provides scientifically rigorous insights into the distribution concentration and health implications of heavy metals in groundwater resources offering valuable evidence for policymakers environmental engineers and public health authorities. His research emphasizes the integration of analytical chemistry environmental monitoring and risk evaluation to ensure safer water systems and promote environmental resilience.Younesi Baneh’s current Scopus metrics include 1 publication 6 citations and an h-index of 1, reflecting early yet impactful engagement in research addressing environmental contamination. He has collaborated with multidisciplinary teams engaging co-authors affiliated with medical sciences environmental engineering and analytical sciences demonstrating strong interdisciplinary alignment and scientific cooperation.Beyond academic contribution the societal impact of his work is significant. His research supports national health strategies by identifying contamination hotspots guiding water treatment interventions and informing community-level environmental policies. Through his commitment to scientific integrity and evidence-based environmental assessment he contributes to safeguarding public health and improving the quality of life in rural communities.With an active ORCID profile (0009-0005-2733-1496) and Scopus ID (59391904400) Payam Younesi Baneh continues to advance research that bridges environmental science and human health aiming to foster sustainable resource management and strengthen regional environmental protection frameworks.

Profiles : ORCID | Scopus

Featured Publications

1.Younesi Baneh, P., Ahmadi, B., Salehzadeh, H., Mohammadi, H., Shahmoradi, B., & Ghaderi, B. (2024). Assessment of heavy metal contamination in groundwater of rural areas of Kurdistan Province Iran: A comprehensive study. Heliyon, e39833.  Cited By : 6

2.Younesi Baneh, P., Najmaddiny, I., Salehzadeh, H., Shahmoradi, B., & Choi, H.-J. (2024). Effect of gold mine activity on water quality and human health. Water Practice & Technology, 19(9).

Reza Amani | Medicine and Health Sciences | Editorial Board Member

Published on by Research Scientist

Prof. Reza Amani | Medicine and Health Sciences | Editorial Board Member

Professor of Clinical Nutrition | Isfahan University of Medical Sciences | Iran

Dr. Reza Amani is a prominent researcher in nutrition science and food security, currently affiliated with the Food Security Research Center at Isfahan University of Medical Sciences Iran. With an extensive academic footprint he has authored 129 scientific documents and accumulated over 3,040 citations across 2,823 citing sources reflecting his sustained contributions to global health and nutrition research. His h-index of 32 underscores the influence and continued relevance of his work in the scientific community. Dr. Amani’s scholarly identity is further established through his Scopus ID: 16314878500 and ORCID: 0000-0002-0074-4080 ensuring transparent and accessible documentation of his academic output.Dr. Amani’s research spans clinical nutrition food insecurity metabolic disorders functional foods and public health interventions. He has led and contributed to numerous high-impact clinical trials and observational studies addressing critical issues such as pregnancy-induced hypertension type 2 diabetes management cognitive function in obese children ischemic stroke recovery and the health risks of ultra-processed food consumption. His recent works also highlight innovative nutritional strategies  including the use of pomegranate peel fortification royal jelly supplementation nuts intake in pediatric obesity and the evaluation of phase angle as a nutritional marker in population health.His systematic reviews and meta-analyses have clarified the nutritional and metabolic effects of bioactive compounds such as heavy metals’ influence on gut microbiota and cocoa’s impact on serum lipids in diabetic patients—providing valuable evidence for clinicians policymakers and public health organizations. With a collaborative network of over 220 co-authors Dr. Amani actively engages in interdisciplinary partnerships that enhance the scientific rigor and societal relevance of his research.Through his commitment to advancing evidence-based nutrition and addressing food insecurity Dr. Amani’s work contributes significantly to improved health outcomes equitable food systems and the global understanding of diet-related chronic diseases. His research continues to inform policy guide clinical practice and inspire future innovations in nutrition science.

Profile : ORCID | Scopus

Featured Publications

1.Amani, R., et al. (2025). Major heavy metals and human gut microbiota composition: A systematic review with nutritional approach. Cited By : 5

2.Amani, R., et al. (2025). Phase angle as an indicator of nutritional status: A cross-sectional study on the Iranian population. Journal of Health, Population and Nutrition.

3.Amani, R., et al. (2025). Effects of pomegranate peel powder-fortified bread consumption in patients with type 2 diabetes mellitus: A randomized controlled trial. Journal of Diabetes and Metabolic Disorders.

4.Amani, R., et al. (2025). Relationship between food insecurity and the risk of pregnancy-induced hypertension: A prospective cohort study. BMC Pregnancy and Childbirth. Cited By : 1

5.Amani, R., et al. (2025). The effects of nuts intake on cognitive and executive function in obese children: A randomized clinical trial. Journal of Health, Population and Nutrition.

Aysel Ozpinar | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Published on by Research Scientist

Research Excellence Award

Aysel Ozpinar — Acibadem University
Aysel Ozpinar
Affiliation Acibadem University
Country Turkey
Scopus ID 6602895292
Documents 88
Citations 1,315
h-index 23
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Research Scientist Awards

The Research Excellence Award article presents an academic overview of Aysel Ozpinar, a researcher affiliated with Acibadem University, Turkey, whose scholarly work in molecular biology, genetics, and biochemical sciences has contributed to the advancement of translational and interdisciplinary biomedical research. The evaluation presented herein is based on publicly accessible academic metrics, indexed publications, citation analyses, and internationally recognized researcher identification systems.[1][2]

Abstract

This article examines the academic accomplishments, publication record, citation performance, and broader scientific influence of Aysel Ozpinar. The profile reflects sustained research productivity across biochemical and molecular biological disciplines, with measurable scholarly influence demonstrated through international indexing systems, bibliometric indicators, and collaborative scientific outputs.[1]

Keywords

  • Research Excellence
  • Biochemistry
  • Genetics
  • Molecular Biology
  • Academic Recognition

Introduction

Recognition through international scientific awards commonly considers publication output, citation impact, mentorship, interdisciplinary collaborations, and contributions to scientific advancement. Within this framework, Aysel Ozpinar demonstrates an established research portfolio aligned with globally recognized academic standards.[2]

Research Profile

The researcher is affiliated with Acibadem University in Turkey and maintains an indexed scholarly identity through Scopus and ORCID platforms. The recorded bibliometric indicators include 88 indexed documents, 1,315 citations, and an h-index of 23, indicating both productivity and sustained citation visibility within the biomedical sciences.[1]

Research Contributions

  • Molecular biomarker research
  • Genomic and proteomic investigations
  • Translational biomedical studies
  • Clinical biochemistry collaborations
  • Interdisciplinary scientific mentoring

Publications

Selected scholarly outputs include publications indexed within major international databases and journals. Representative digital object identifiers demonstrate accessibility and citation interoperability across academic platforms.[3]

Research Impact

Bibliometric evaluation indicates consistent citation accumulation, cross-disciplinary engagement, and measurable academic influence across biomedical research communities. The citation count and h-index collectively suggest continued relevance of published findings in subsequent scientific investigations.[1]

Award Suitability

Based on bibliometric performance, international researcher identification, publication continuity, and interdisciplinary contribution, the research profile demonstrates compatibility with the evaluation criteria commonly associated with the International Research Scientist Awards.[4]

Conclusion

Aysel Ozpinar represents an established academic contributor in biochemistry, genetics, and molecular biology. The combination of publication productivity, citation influence, international visibility, and scientific engagement provides a comprehensive foundation for recognition within international research award frameworks.

References

  1. Elsevier. (n.d.). Scopus author details: Aysel Ozpinar, Author ID 6602895292. Scopus.https://www.scopus.com/
  2. ORCID. (n.d.). Researcher profile of Aysel Ozpinar. ORCID Registry.https://orcid.org/0000-0002-7399-4929
  3. Crossref. (n.d.). Digital object identifier records for indexed biomedical publications.https://doi.org/
  4. International Research Scientist Awards. (n.d.). Award criteria and nomination framework.https://researchscientist.net/